Marker Therapeutics Inc (MRKR)

[hyperopia]

Sorry my post wasn’t very clear. Agreed, the extension doesn’t have anything to do with the up coming vote, and it was wisely provided for in the agreement. The merger was expected to be wrapped up by September 15th, and yet the deal’s still not done. I wasn’t implying that there is something wrong with Marker that caused the other deals to fall through, just that deals fall through all the time for many reasons, so this isn’t a sure thing either. I’m not as informed as you are, so I’m not as confident that the vote’s in the bag

I’m also not saying that I think it’s not running higher because the prior Marker deals fell through. We agree, it’s likely some deep pocketed investors are sitting it out until the merger is final. Some money is less risk tolerant and would rather pay, say $13 after the deal closes, then say, $9 before with even a small possibility of it falling back to $3 if "something catastrophic” happens.

Thanks for the interesting Battersea Biotech background. You’re really a wealth of information, and this board is fortunate you’re here.